BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 21475699)

  • 1. Cachexia as a major underestimated and unmet medical need: facts and numbers.
    von Haehling S; Anker SD
    J Cachexia Sarcopenia Muscle; 2010 Sep; 1(1):1-5. PubMed ID: 21475699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016.
    von Haehling S; Anker MS; Anker SD
    J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):507-509. PubMed ID: 27891294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014.
    von Haehling S; Anker SD
    J Cachexia Sarcopenia Muscle; 2014 Dec; 5(4):261-3. PubMed ID: 25384990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact.
    Konishi M; Ishida J; Springer J; Anker SD; von Haehling S
    J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):515-519. PubMed ID: 27239422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney cachexia or protein-energy wasting in chronic kidney disease: facts and numbers.
    Koppe L; Fouque D; Kalantar-Zadeh K
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):479-484. PubMed ID: 30977979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. It's more than low BMI: prevalence of cachexia and associated mortality in COPD.
    McDonald MN; Wouters EFM; Rutten E; Casaburi R; Rennard SI; Lomas DA; Bamman M; Celli B; Agusti A; Tal-Singer R; Hersh CP; Dransfield M; Silverman EK
    Respir Res; 2019 May; 20(1):100. PubMed ID: 31118043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The syndrome of cardiac cachexia.
    Anker SD; Sharma R
    Int J Cardiol; 2002 Sep; 85(1):51-66. PubMed ID: 12163209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation.
    Anker SD; Coats AJ
    Chest; 1999 Mar; 115(3):836-47. PubMed ID: 10084500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia.
    Filippatos GS; Kanatselos C; Manolatos DD; Vougas B; Sideris A; Kardara D; Anker SD; Kardaras F; Uhal B
    Int J Cardiol; 2003 Jul; 90(1):107-13. PubMed ID: 12821225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and Skeletal Muscle Wasting During Cachexia.
    Webster JM; Kempen LJAP; Hardy RS; Langen RCJ
    Front Physiol; 2020; 11():597675. PubMed ID: 33329046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of weight loss in chronic obstructive pulmonary disease-related cachexia: a prospective cohort study.
    Kwan HY; Maddocks M; Nolan CM; Jones SE; Patel S; Barker RE; Kon SSC; Polkey MI; Cullinan P; Man WD
    J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1330-1338. PubMed ID: 31207189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
    Anker SD; Rauchhaus M
    Curr Opin Cardiol; 1999 May; 14(3):211-6. PubMed ID: 10358792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional strategy in the management of heart failure in adults.
    Bourdel-Marchasson I; Emeriau JP
    Am J Cardiovasc Drugs; 2001; 1(5):363-73. PubMed ID: 14728018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent insights on chronic heart failure, cachexia and nutrition.
    Miján-de-la-Torre A
    Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):251-7. PubMed ID: 19363338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible synergism of physical exercise and ghrelin-agonists in patients with cachexia associated with chronic heart failure.
    Invernizzi M; Carda S; Cisari C;
    Aging Clin Exp Res; 2014 Aug; 26(4):341-51. PubMed ID: 24347122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing a clinical phenotype for cachexia in end stage kidney disease - study protocol.
    Reid J; Noble HR; Adamson G; Davenport A; Farrington K; Fouque D; Kalantar-Zadeh K; Mallett J; McKeaveney C; Porter S; Seres DS; Shields J; Slee A; Witham MD; Maxwell AP
    BMC Nephrol; 2018 Feb; 19(1):38. PubMed ID: 29439674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cachexia: prevalence and impact in medicine.
    Tan BH; Fearon KC
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):400-7. PubMed ID: 18541999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
    Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M
    Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches.
    Akashi YJ; Springer J; Anker SD
    Curr Heart Fail Rep; 2005 Dec; 2(4):198-203. PubMed ID: 16332313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.